BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 21162645)

  • 1. Rupatadine for the treatment of allergic rhinitis and urticaria.
    Metz M; Maurer M
    Expert Rev Clin Immunol; 2011 Jan; 7(1):15-20. PubMed ID: 21162645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
    González-Núñez V; Bachert C; Mullol J
    Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
    Picado C
    Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
    Izquierdo I; Merlos M; García-Rafanell J
    Drugs Today (Barc); 2003 Jun; 39(6):451-68. PubMed ID: 12944997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rupatadine: a review of its use in the management of allergic disorders.
    Keam SJ; Plosker GL
    Drugs; 2007; 67(3):457-74. PubMed ID: 17335300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
    Martínez-Cócera C; De Molina M; Martí-Guadaño E; Pola J; Conde J; Borja J; Pérez I; Arnaiz E; Izquierdo I;
    J Investig Allergol Clin Immunol; 2005; 15(1):22-9. PubMed ID: 15864879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
    Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Potter P; Maspero JF; Vermeulen J; Barkai L; Németh I; Baillieau RA; Garde JM; Giralt J; Doménech A; Izquierdo I; Nieto A
    Pediatr Allergy Immunol; 2013 Mar; 24(2):144-50. PubMed ID: 23384091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H1-antihistamines in the elderly.
    Kaliner MA
    Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
    Saint-Martin F; Dumur JP; Pérez I; Izquierdo I;
    J Investig Allergol Clin Immunol; 2004; 14(1):34-40. PubMed ID: 15160440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
    Compalati E; Canonica GW
    Curr Med Res Opin; 2013 Nov; 29(11):1539-51. PubMed ID: 23826741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levocetirizine (Xyzal) for allergic rhinitis and urticaria.
    Med Lett Drugs Ther; 2007 Dec; 49(1275):97-9. PubMed ID: 18046285
    [No Abstract]   [Full Text] [Related]  

  • 17. Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I
    J Biol Regul Homeost Agents; 2010; 24(2):177-83. PubMed ID: 20487631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1-antihistamines in children.
    Simons FE
    Clin Allergy Immunol; 2002; 17():437-64. PubMed ID: 12113226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
    Maiti R; Rahman J; Jaida J; Allala U; Palani A
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.